Skip to main content
Fig. 5 | Clinical Proteomics

Fig. 5

From: Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer

Fig. 5

ROC curves representing the diagnostic performance of biomarker candidates between CRC patients with non-metastatic and metastatic stages. The upper charts demonstrated ROC curves of each biomarker candidate in (A) the study-cohort and (C) the validation-cohort. The bottom charts demonstrated ROC curves of the combination sets in (B) the study-cohort and (D) the validation-cohort. Details of the area under the ROC curve (AUC) with 95% confidence interval (CI), sensitivity and specificity of each protein candidate and the most effective combinations were shown in the Table 5.

Back to article page

Clinical Proteomics

ISSN: 1559-0275